Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Warfield

Pediatrics Washington, DC Medical Doctor

NPI 1225116502 CMS profile 9955

4850 Massachusetts Ave Nw Ste 200, Washington, DC 20016

Open in the dashboard

General payments

$8,500

142 records reported · program years 2019–2025

Research payments

$10,300

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$305,189 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Peter Warfield of Washington, DC is reported in the CMS Open Payments database as having received $8,500 across 142 general payments and $10,300 in research payments paid to them. Separately, studies naming them as principal investigator received $305,189 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,172 27
2024 General $478 24
2023 General $505 19
2023 Research $10,300 2
2022 General $404 20
2021 General $425 23
2020 General $154 9
2019 General $361 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Warfield
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Peter Warfield were reported at $6,172. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Peter Warfield Pediatrics median Middle half National median
2019 $361 $86 $31–$183 $163
2020 $154 $49 $22–$110 $114
2021 $425 $68 $27–$158 $132
2022 $404 $77 $30–$173 $149
2023 $505 $88 $33–$190 $160
2024 $478 $94 $34–$206 $164
2025 $6,172 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $6,139 25 payments
  2. Merck Sharp & Dohme Corporation $426 20 payments
  3. Cranial Technologies, Inc $337 24 payments
  4. Supernus Pharmaceuticals, Inc. $286 15 payments
  5. Sanofi-Aventis U.S. LLC $269 6 payments
  6. kaleo, Inc. $266 12 payments
  7. Sanofi Pasteur Inc. $101 5 payments
  8. Adlon Therapeutics L.P. $88 5 payments
  9. AstraZeneca Pharmaceuticals LP $66 3 payments
  10. Phadia US Inc. $65 4 payments
  11. Other $458 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $4,275 2 payments
  2. Food and Beverage $3,134 136 payments
  3. Travel and Lodging $1,042 3 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50 1 payment
Products named General payments · program years 2019–2025
  1. COMIRNATY $5,938 15 payments
  2. Doc Band $337 24 payments
  3. GARDASIL 9 $295 14 payments
  4. QELBREE $286 15 payments
  5. TRUMENBA $275 14 payments
  6. TZIELD $269 6 payments
  7. VAXELIS $263 12 payments
  8. VAXNEUVANCE $233 10 payments
  9. AUVI-Q $208 10 payments
  10. PREVNAR 20 $138 7 payments
  11. Other $1,671 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pfizer Inc. $10,300 2 payments

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record